Thus, although erlotinib was reaching the CNS and having a pharmacodynamic effect in the spinal cord, we conclude that erlotinib is not efficacious in treating the SOD1 mouse model of ALS. Here, SOD1 is linked to amyotrophic lateral sclerosis.